首页> 外文期刊>The Journal of toxicological sciences >Human induced pluripotent stem cell-derived mast cells useful for in vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells
【24h】

Human induced pluripotent stem cell-derived mast cells useful for in vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells

机译:人类诱导的多能干细胞衍生的肥大细胞可用于体外肥大细胞活化测定表现出人肥大细胞的表型和形态特征

获取原文
获取原文并翻译 | 示例
       

摘要

Mast cells are key players in the inflammatory response with an important role in allergic reactions and are therefore useful for assessing the risk of anaphylaxis. However, they are difficult to isolate due to their low abundance and wide distribution. To overcome this, we generated and characterized mast cell-like cells derived from human induced pluripotent stem (hiPS) cells. These hiPS cell-derived mast cells (hiPS-MCs) were generated using recombinant human bone morphogenetic protein 4 (BMP4), vascular endothelial growth factor 165 (VEGF), stem cell factor (SCF), interleukin-4 (IL-4), interleukin-6 (IL-6), and interleukin-9 (IL-9) in a StemPro-34 medium. The hiPS-MCs exhibited the morphological characteristics of human mast cells, expressing high affinity-IgE receptor (Fc epsilon RI) and mast cell markers such as tryptase, chymase, and CD117. In addition, FcERI stimulation with agonistic anti-IgE functionally increased the expression of activation markers CD63 and CD203c, as well as the amount of released histamine. We think the hiPS-MCs generated in this study will be useful for assessing the pharmacology and toxicity of anti-allergy medicines.
机译:肥大细胞是炎症反应中的关键球员,具有过敏反应中的重要作用,因此可用于评估过敏反应的风险。然而,由于其低丰度和广泛的分布,它们难以隔离。为了克服这一点,我们产生和表征衍生自人诱导的多能干(臀部)细胞的肥大细胞样细胞。使用重组人骨形态发生蛋白4(BMP4),血管内皮生长因子165(VEGF),干细胞因子(SCF),白细胞介素-4(IL-4)产生这些髋细胞衍生的肥大细胞(HIPS-MCS),白细胞介素-6(IL-6)和白细胞介素-9(IL-9)在StemPro-34培养基中。 HIPS-MCS表现出人肥大细胞的形态特征,表达高亲和力-IgE受体(FCεRI)和肥大细胞标记,例如胰蛋白酶,冠酶和CD117。此外,具有激动抗IgE的Fceri刺激功能升高了活化标志物CD63和CD203c的表达,以及释放的组胺的量​​。我们认为本研究中产生的HIPS-MCS将有助于评估抗过敏药物的药理和毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号